Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
32.74
+0.10 (0.31%)
At close: Oct 8, 2025, 4:00 PM EDT
32.51
-0.23 (-0.70%)
After-hours: Oct 8, 2025, 6:52 PM EDT
Genmab Stock Forecast
Stock Price Forecast
The 6 analysts that cover Genmab stock have a consensus rating of "Strong Buy" and an average price target of $41.17, which forecasts a 25.75% increase in the stock price over the next year. The lowest target is $27 and the highest is $48.
Price Target: $41.17 (+25.75%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 4 | 4 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $40 | Strong Buy | Maintains | $36 → $40 | +22.17% | Oct 2, 2025 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $43 | Hold → Strong Buy | Upgrades | $43 | +31.34% | Sep 24, 2025 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $43 | Hold → Strong Buy | Upgrades | $43 | +31.34% | Sep 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $36 | Strong Buy | Maintains | $35 → $36 | +9.96% | Aug 15, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $45 → $46 | Strong Buy | Maintains | $45 → $46 | +40.50% | Jul 8, 2025 |
Financial Forecast
Revenue This Year
3.71B
from 2.99B
Increased by 24.25%
Revenue Next Year
4.32B
from 3.71B
Increased by 16.29%
EPS This Year
16.69
from 16.85
Decreased by -0.93%
EPS Next Year
19.59
from 16.69
Increased by 17.36%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.9B | 4.8B | |||
| Avg | 3.7B | 4.3B | |||
| Low | 3.5B | 3.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 30.9% | 30.2% | |||
| Avg | 24.3% | 16.3% | |||
| Low | 16.3% | 5.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.83 | 26.29 | |||
| Avg | 16.69 | 19.59 | |||
| Low | 12.01 | 11.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.7% | 57.5% | |||
| Avg | -0.9% | 17.4% | |||
| Low | -28.7% | -28.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.